| Title : Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease - Riley_2009_IDrugs_12_648 |
| Author(s) : Riley RF , Corson MA |
| Ref : IDrugs , 12 :648 , 2009 |
| Abstract : |
| PubMedSearch : Riley_2009_IDrugs_12_648 |
| PubMedID: 19790016 |
| Title : Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease - Riley_2009_IDrugs_12_648 |
| Author(s) : Riley RF , Corson MA |
| Ref : IDrugs , 12 :648 , 2009 |
| Abstract : |
| PubMedSearch : Riley_2009_IDrugs_12_648 |
| PubMedID: 19790016 |
| Title : Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease - Riley_2009_IDrugs_12_648 |
| Author(s) : Riley RF , Corson MA |
| Ref : IDrugs , 12 :648 , 2009 |
| Abstract : |
| PubMedSearch : Riley_2009_IDrugs_12_648 |
| PubMedID: 19790016 |